Abstract

Despite contributing to the large disease burden in West Africa, little is known about the genomic epidemiology of Streptococcus pneumoniae which cause meningitis among children under 5 years old in the region. We analysed whole-genome sequencing data from 185 S. pneumoniae isolates recovered from suspected paediatric meningitis cases as part of the World Health Organization (WHO) invasive bacterial diseases surveillance from 2010 to 2016. The phylogeny was reconstructed, accessory genome similarity was computed and antimicrobial-resistance patterns were inferred from the genome data and compared to phenotypic resistance from disc diffusion. We studied the changes in the distribution of serotypes pre- and post-pneumococcal conjugate vaccine (PCV) introduction in the Central and Western sub-regions separately. The overall distribution of non-vaccine, PCV7 (4, 6B, 9V, 14, 18C, 19F and 23F) and additional PCV13 serotypes (1, 3, 5, 6A, 19A and 7F) did not change significantly before and after PCV introduction in the Central region (Fisher's test P value 0.27) despite an increase in the proportion of non-vaccine serotypes to 40 % (n=6) in the post-PCV introduction period compared to 21.9 % (n=14). In the Western sub-region, PCV13 serotypes were more dominant among isolates from The Gambia following the introduction of PCV7, 81 % (n=17), compared to the pre-PCV period in neighbouring Senegal, 51 % (n=27). The phylogeny illustrated the diversity of strains associated with paediatric meningitis in West Africa and highlighted the existence of phylogeographical clustering, with isolates from the same sub-region clustering and sharing similar accessory genome content. Antibiotic-resistance genotypes known to confer resistance to penicillin, chloramphenicol, co-trimoxazole and tetracycline were detected across all sub-regions. However, there was no discernible trend linking the presence of resistance genotypes with the vaccine introduction period or whether the strain was a vaccine or non-vaccine serotype. Resistance genotypes appeared to be conserved within selected sub-clades of the phylogenetic tree, suggesting clonal inheritance. Our data underscore the need for continued surveillance on the emergence of non-vaccine serotypes as well as chloramphenicol and penicillin resistance, as these antibiotics are likely still being used for empirical treatment in low-resource settings. This article contains data hosted by Microreact.

Highlights

  • Streptococcus pneumoniae is one of the top three causes of acute bacterial meningitis, the most severe form of meningitis [1]

  • Study design The World Health Organization (WHO) IB-­VPD surveillance is supported by the WHO Collaborating Centre (WHO CC) for New Vaccines Surveillance hosted by the Medical Research Council Unit The Gambia at the London School of Hygiene and Tropical Medicine (MRCG)

  • We analysed 185 genomes of pneumococci isolated from paediatric meningitis patients across West Africa and parts of Central Africa

Read more

Summary

Introduction

Streptococcus pneumoniae (the pneumococcus) is one of the top three causes of acute bacterial meningitis, the most severe form of meningitis [1]. Despite the availability of effective vaccines, acute bacterial meningitis due to the pneumococcus continues to be a major cause of morbidity and mortality in sub-S­ aharan Africa, especially among children under 5 years old [2]. The 10- or 13-v­ alent pneumococcal conjugate vaccine (PCV10 and PCV13 respectively), which target the most prevalent serotypes in serious disease, have been introduced in 39/47 countries in. PCVs have been effective at reducing invasive disease caused by vaccine serotypes in high-­income countries and low-r­ esource settings [3,4,5,6,7]

Methods
Results
Discussion
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call